DRMA logo

Dermata Therapeutics, Inc. Stock Price

NasdaqCM:DRMA Community·US$4.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

DRMA Share Price Performance

US$1.25
-6.45 (-83.77%)
US$1.25
-6.45 (-83.77%)
Price US$1.25

DRMA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with adequate balance sheet.

6 Risks
1 Reward

Dermata Therapeutics, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$7.1m

Other Expenses

-US$7.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-1.77
0%
0%
0%
View Full Analysis

About DRMA

Founded
2014
Employees
9
CEO
Gerald Proehl
WebsiteView website
www.dermatarx.com

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Recent DRMA News & Updates

Recent updates

No updates